By Aimee Look
Haleon booked a rise in organic revenue, led by growth in its oral health segment, which houses brands like Sensodyne toothpaste.
The maker of Panadol and Advil tablets said revenue for the first quarter rose 2.2% on an organic basis to 2.86 billion pounds ($3.87 billion).
Company-compiled analyst estimates saw revenue for the first quarter at 2.85 billion pounds.
Revenue in North America rose 1% on an organic basis to 932 million pounds, despite a weak cold and flu season.
The strongest product category was oral health, with 8.3% organic growth, which was driven by Sensodyne and Parodontax products, Haleon said.
The company said it expects organic revenue growth of 3% to 5% for the full year.
Write to Aimee Look at aimee.look@wsj.com
(END) Dow Jones Newswires
04-29-26 0239ET
